Sinoway Industrial Co., Ltd.

Apixaban 503612-47-3 Apixaban 503612-47-3

Apixaban 503612-47-3
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.


Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :


Apixaban 503612-47-3


  • Valsartan 137862-53-4
    Basic information of Valsartan:NameValsartanMolecular FormulaC24H29N5O3Molecular Weight435.52Quality StandardEP/USP/JPPackage Size25kg/drumBrief IntroductionValsartan (trade name Diovan) is an angiote... Valsartan 137862-53-4
  • Metformin 657-24-9
    Basic information of Metformin:NameMetforminMolecular FormulaC4H11N5Molecular Weight129.16Quality StandardEP/USP/BPPackage Size25kg/drumBrief IntroductionMetformin, marketed under the tradename Glucop... Metformin 657-24-9
  • Donepezil 120014-06-4
    Basic information of DonepezilNameDonepezilAlias2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-oneCAS Number120014-06-4Molecular FormulaC24H29NO3Molecular Weight379.49Quality Standa... Donepezil 120014-06-4
  • Diosmin Hesperidin 90:10 powder
    Basic information of Diosmin:NameDiosminCAS520-27-4EINECS208-289-7Molecular FormulaC28H32O15Molecular Weight609Quality Standard EP8.0Package Size25kg/drumBrief IntroductionGreyish-yellow or light yell... Diosmin Hesperidin 90:10 powder

MORE_DETAIL Apixaban 503612-47-3

Basic information of Apixaban :

Name

Apixaban

Alias

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS NO.

503612-47-3

Molecular Formula

C25H25N5O4

Molecular Weight

459.504

EINECS

1308068-626-2

Brief Introduction

Apixaban is a novel, oral, reversible, highly selective, direct Factor Xa inhibitor developed by Pfizer and Bristol-Myers Squibb.

Storage condition

Room temperature, seal.


Use of Apixaban:

The results of the study show that compared with traditional anticoagulants, Apixaban is more effective and does not increase or decrease the risk of bleeding. Currently, the US FDA and the European EMA have approved Apixaban for prevention of venous thromboembolism (also known as venous thromboembolism or VTE) in adults undergoing total hip or total knee arthroplasty to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation ( Also known as atrial fibrillation stroke), treatment of deep vein thromboembolism (also known as deep vein thrombosis or DVT) and pulmonary embolism (also known as PE), and prevention of recurrence of DVT and PE.

COA of Apixaban :


Apixaban 503612-47-3

Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//